Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
interferon alpha-2b (Intron-A) (1 trial)
lomibuvir (1 trial)
ribavirin (virazole) (1 trial)
vch-759 (1 trial)
vch-916 (1 trial)
Communicable Diseases (Phase 1)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis C (Phase 2)
Hepatitis C, Chronic (Phase 2)
Infections (Phase 1)
Trials (3 total)
Trial APIs (5 total)